NL-OMON46237已完成不适用
A single-dose, open label, randomized, three-way cross-over study in healthy volunteers to characterize the pharmacokinetics of the 300 mg trientine capsule and to assess the effect of dissolution rate and the effect of food on the pharmacokinetics of trientine. - 180194-CS0298 Univar
nivar BV0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male or female subjects;Females must not be pregnant or breastfeeding and must be postmenopausal or agree to use an acceptable form of birth control;Aged 18 to 75 years inclusive at screening.;For more inclusion criteria a reference is made to the protocol.
排除标准
- •Has smoked more than 5 cigarettes or equivalents tobacco products per day within 14 days prior to the first dose of study medication.;History or presence of drug or alcohol abuse within the past 5 years. ;For more exclusion criteria a reference is made to the protocol.
研究者
相似试验
尚未招募
不适用
A randomized, open-label, single dose, three-way crossover clinical trial to investigate the pharmacokinetics incorporating a comparison of fed/fasted pharmacokinetics of HIP1402 in healthy male volunteersDiseases of The genitoruinary systemKCT0001610Hanmi Pharm24
进行中（未招募）
1 期
A single-dose, open-label, randomised, three-way crossover study to assess the comparative bioavailability of Captopril oral solution 5 mg/mL relative to captopril tablets and to investigate the effect of food on the pharmacokinetics of Captopril oral solution in healthy adult volunteersCaptopril 5 mg/mL oral solution is a new oral pharmaceutical formulation intended for the treatment of congestive heart failure in male and female paediatric patients from birth to 18 years.EUCTR2019-000258-76-ESProveca Ltd.24
进行中（未招募）
不适用
Clinical study to test that the drug CHF 1535 100/6 (fixed combination of an anti-inflammatory drug and relaxing airways drug) delivered via pressurized inhaler using or not a spacer device is as effective in adolescent population as the licensed free combination of the same substances and compare it with administration in adults.MedDRA version: 14.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2011-005108-14-PLChiesi Farmaceutici S.p.A.
已完成
不适用
A clinical trial to investigate the pharmacokinetic drug-drug interaction of Cilnidipine 10 mg and Valsartan 160 mg in healthy male volunteersKCT0000763Ildong pharmaceutical54
已完成
不适用
Relative bioavailability study of two candidate tablet formulations of 16mg candesartan cilexetil (GW615775) compared with the reference product Atacand (16mg candesartan cilexetil, AstraZeneca) in healthy human subjects under fasting conditionsCTRI/2014/12/005269GlaxoSmithKline Research and Development Limited18